Found: 61
Select item for more details and to access through your institution.
The relationship between patients' serum glucose levels and metabolically active brown adipose tissue detected by PET/CT.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 181, n. 2, p. 383, doi. 10.1007/s10549-020-05631-4
- By:
- Publication type:
- Article
The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2017, v. 24, n. 9, p. 2563, doi. 10.1245/s10434-017-5903-6
- By:
- Publication type:
- Article
Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 8, p. 2483, doi. 10.1245/s10434-015-4469-4
- By:
- Publication type:
- Article
Report on the PET/CT Image--Based Radiation Dosimetry of [<sup>18</sup>F]FDHT in Women, a Validated Imaging Agent with New Applications for Evaluation of Androgen Receptor Status in Women with Metastatic Breast Cancer.
- Published in:
- Journal of Nuclear Medicine Technology, 2023, v. 51, n. 4, p. 1, doi. 10.2967/jnmt.123.265623
- By:
- Publication type:
- Article
Report on the PET/CT Image–Based Radiation Dosimetry of [<sup>18</sup> F]FDHT in Women, a Validated Imaging Agent with New Applications for Evaluation of Androgen Receptor Status in Women with Metastatic Breast Cancer.
- Published in:
- Journal of Nuclear Medicine Technology, 2023, v. 51, n. 3, p. 204, doi. 10.2967/jnmt.123.265623
- By:
- Publication type:
- Article
<sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
<sup>177</sup>Lu-Vipivotide Tetraxetan (<sup>177</sup>Lu-PSMA-617, Pluvicto) Therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Guidance on <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy from the Experience of a Single Nuclear Medicine Division.
- Published in:
- Journal of Nuclear Medicine Technology, 2018, v. 46, n. 3, p. 237, doi. 10.2967/jnmt.118.209148
- By:
- Publication type:
- Article
<sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Refractory myeloid sarcoma with a FIP1L1-PDGFRA rearrangement detected by clinical high throughput somatic sequencing.
- Published in:
- Experimental Hematology & Oncology, 2015, v. 4, n. 1, p. 1, doi. 10.1186/s40164-015-0026-x
- By:
- Publication type:
- Article
Prospective SPECT-CT Organ Dosimetry-Driven Radiation-Absorbed Dose Escalation Using the In-111 (111 In)/Yttrium 90 (90 Y) Ibritumomab Tiuxetan (Zevalin ®) Theranostic Pair in Patients with Lymphoma at Myeloablative Dose Levels.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2828, doi. 10.3390/cancers13112828
- By:
- Publication type:
- Article
Inflammatory breast cancer and development of brain metastases: risk factors and outcomes.
- Published in:
- 2015
- By:
- Publication type:
- Report
Scalene muscle uptake: a potential pitfall in head and neck PET/CT.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 1, p. 89, doi. 10.1007/s00259-007-0548-5
- By:
- Publication type:
- Article
Phase I Trial of Oxaliplatin, Infusional 5-Fluorouracil, and Leucovorin (FOLFOX4) With Erlotinib and Bevacizumab in Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2010, v. 9, n. 5, p. 297, doi. 10.3816/CCC.2010.n.043
- By:
- Publication type:
- Article
Standard Adult Gastric Emptying Scintigraphy Criteria Is Applicable for Partial Meal Ingestion.
- Published in:
- Digestive Diseases & Sciences, 2023, v. 68, n. 2, p. 541, doi. 10.1007/s10620-022-07667-6
- By:
- Publication type:
- Article
The Current and Future Roles of Precision Oncology in Advanced Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.122.264882
- By:
- Publication type:
- Article
The Current and Future Roles of Precision Oncology in Advanced Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 349, doi. 10.2967/jnumed.122.264882
- By:
- Publication type:
- Article
The Current and Future Roles of Precision Oncology in Advanced Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.122.264882
- By:
- Publication type:
- Article
SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-PSMA-617 Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1417, doi. 10.2967/jnumed.123.265952
- By:
- Publication type:
- Article
Clinical Implementation of <sup>177</sup>Lu-PSMA-617 in the United States: Lessons Learned and Ongoing Challenges.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 3, p. 349, doi. 10.2967/jnumed.122.265194
- By:
- Publication type:
- Article
SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 204, doi. 10.2967/jnumed.122.264860
- By:
- Publication type:
- Article
Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, p. 23S, doi. 10.2967/jnumed.121.262751
- By:
- Publication type:
- Article
Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, p. 60S, doi. 10.2967/jnumed.121.262977
- By:
- Publication type:
- Article
Imaging Androgen Receptors in Breast Cancer with <sup>18</sup>F-fluoro-5α-dihydrotestosterone- PET: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262068
- By:
- Publication type:
- Article
Imaging Androgen Receptors in Breast Cancer with <sup>18</sup>F-fluoro-5α-dihydrotestosterone- PET: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262068
- By:
- Publication type:
- Article
Imaging Androgen Receptors in Breast Cancer with <sup>18</sup>F-fluoro-5α-dihydrotestosteronePET: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262068
- By:
- Publication type:
- Article
Imaging Androgen Receptors in Breast Cancer with <sup>18</sup>F-fluoro-5α-dihydrotestosterone-PET: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262068
- By:
- Publication type:
- Article
Imaging Androgen Receptors in Breast Cancer with <sup>18</sup>F-fluoro-5α-dihydrotestosterone-PET: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.262068
- By:
- Publication type:
- Article
Imaging Androgen Receptors in Breast Cancer with <sup>18</sup>F-fluoro-5α-dihydrotestosterone-PET: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.121.262068
- By:
- Publication type:
- Article
2019 SNMMI Highlights Lecture: General Nuclear Medicine and Molecular Imaging.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 10, p. 13N
- By:
- Publication type:
- Article
2018 SNMMI Highlights Lecture: General Nuclear Medicine.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 10, p. 7N
- By:
- Publication type:
- Article
Quantitation of Cancer Treatment Response by <sup>18</sup>F-FDG PET/CT: Multicenter Assessment of Measurement Variability.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 9, p. 1429, doi. 10.2967/jnumed.117.189605
- By:
- Publication type:
- Article
Molecular Imaging Training for Nuclear Medicine Residents.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 4, p. 655, doi. 10.2967/jnumed.112.103994
- By:
- Publication type:
- Article
Molecular Imaging Training Course Debuts.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 1, p. 16N
- By:
- Publication type:
- Article
Predicting Hematologic Toxicity in Patients Undergoing Radioimmunotherapy with <sup>90</sup>Y-Ibritumomab Tiuxetan or <sup>131</sup>I-Tositumomab.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 12, p. 1878, doi. 10.2967/jnumed.110.079947
- By:
- Publication type:
- Article
Arterial Wall Dosimetry for Non-Hodgkin Lymphoma Patients Treated with Radioimmunotherapy.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 3, p. 368, doi. 10.2967/jnumed.109.069575
- By:
- Publication type:
- Article
CT Hounsfield Units of Brown Adipose Tissue Increase with Activation: Preclinical and Clinical Studies.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 2, p. 246, doi. 10.2967/jnumed.109.068775
- By:
- Publication type:
- Article
Prediction of the Need for Surgical Intervention in Obstructive Crohn's Disease by <sup>18</sup>F-FDG PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 11, p. 1751, doi. 10.2967/jnumed.109.065466
- By:
- Publication type:
- Article
Assessment of Interobserver Reproducibility in Quantitative <sup>18</sup>F-FDG PET and CT Measurements of Tumor Response to Therapy.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 11, p. 1760, doi. 10.2967/jnumed.109.063321
- By:
- Publication type:
- Article
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 5, p. 122S, doi. 10.2967/jnumed.108.057307
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT for Monitoring the Response of Lymphoma to Radioimmunotherapy.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 1, p. 8, doi. 10.2967/jnumed.108.055376
- By:
- Publication type:
- Article
Diagnosis and Differentiation of Bronchioloalveolar Carcinoma from Adenocarcinoma with Bronchioloalveolar Components with Metabolic and Anatomic Characteristics Using PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 10, p. 1585, doi. 10.2967/jnumed.108.052712
- By:
- Publication type:
- Article
Reproducibility of Tumor Blood Flow Quantification with <sup>15</sup>O-Water PET.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 10, p. 1620, doi. 10.2967/jnumed.108.052076
- By:
- Publication type:
- Article
Correlation of 68Ga-DOTATATE uptake on PET/CT with pathologic features of cellular proliferation in neuroendocrine neoplasms.
- Published in:
- Annals of Nuclear Medicine, 2021, v. 35, n. 9, p. 1066, doi. 10.1007/s12149-021-01642-3
- By:
- Publication type:
- Article
No delayed imaging or CCK administration is needed in most cases when bowel excretion does not occur but gallbladder fills promptly.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparison of organ residence time estimation methods for radioimmunotherapy dosimetry and treatment planning—patient studies.
- Published in:
- Medical Physics, 2009, v. 36, n. 5, p. 1595, doi. 10.1118/1.3100265
- By:
- Publication type:
- Article
Evaluation of quantitative imaging methods for organ activity and residence time estimation using a population of phantoms having realistic variations in anatomy and uptake.
- Published in:
- Medical Physics, 2009, v. 36, n. 2, p. 612, doi. 10.1118/1.3063156
- By:
- Publication type:
- Article
Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers.
- Published in:
- 2022
- By:
- Publication type:
- journal article